Stock Events

Stock Events

Halozyme Therapeutics (HALO) Q2 2026 Earnings

11MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Q2 2026

-0.24

0.57

1.39

2.2

Details

Expected EPS

1.545

Actual EPS

1.6

Surprise EPS

0.06

Surprise Percent

+3.56%

Description

Halozyme Therapeutics (HALO) has reported earnings of 1.6 per share for Q2 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.